EBANGA
These highlights do not include all the information needed to use EBANGA™ safely and effectively. See full prescribing information for EBANGA. EBANGA (ansuvimab-zykl) for injection, for intravenous use Initial U.S. Approval: 2020
Approved
Approval ID
9c008384-379d-48d3-b5a5-9809ed0f655c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 23, 2022
Manufacturers
FDA
Ridgeback Biotherapeutics, LP
DUNS: 116921498
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ANSUVIMAB
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code80673-777
Application NumberBLA761172
Product Classification
M
Marketing Category
C73585
G
Generic Name
ANSUVIMAB
Product Specifications
Effective DateMay 23, 2022
FDA Product Classification